Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway

Journal of Molecular and Cellular Cardiology

Volumn 47, Issue 6, 2009, Pages 798-809

  Min, Li Juan ^a   Mogi, Masaki ^a   Tamura, Kouichi ^b   Iwanami, Jun ^a   Sakata, Akiko ^a   Fujita, Teppei ^a   Tsukuda, Kana ^a   Jing, Fei ^a   Iwai, Masaru ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II type 1 receptor associated protein; Calcineurin nuclear factor of activated T cells; Senescence; Vascular disease; Vascular smooth muscle cell

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR ASSOCIATED PROTEIN; BETA GALACTOSIDASE; CALCINEURIN; CYCLOSPORIN A; PROTEIN P21; PROTEIN P53; RECEPTOR PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; VALSARTAN;

ANIMAL CELL; ARTICLE; CELL AGING; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II; ANIMALS; CALCINEURIN; CELL AGING; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; ENZYME ACTIVATION; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NFATC TRANSCRIPTION FACTORS; OXIDATIVE STRESS; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

MUS;

EID: 70449115552     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.09.006     Document Type: Article

References (37)

1. de Gasparo M., Catt K.J., Inagami T., Wright J.W., and Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52 (2000) 415-472
2. Carey R.M., and Siragy H.M. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr. Rev. 24 (2003) 261-271
3. Bockaert J., Marin P., Dumuis A., and Fagni L. The 'magic tail' of G protein-coupled receptors: an anchorage for functional protein networks. FEBS Lett. 546 (2003) 65-72
4. Daviet L., Lehtonen J.Y., Tamura K., Griese D.P., Horiuchi M., and Dzau V.J. Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J. Biol. Chem. 274 (1999) 17058-17062
5. Tamura K., Tanaka Y., Tsurumi Y., Azuma K., Shigenaga A., Wakui H., et al. The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and function. Curr. Hypertens Rep. 9 (2007) 121-127
6. Azuma K., Tamura K., Shigenaga A., Wakui H., Masuda S., Tsurumi-Ikeya Y., et al. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells. Hypertension 50 (2007) 926-932
7. Cui T., Nakagami H., Iwai M., Takeda Y., Shiuchi T., Tamura K., et al. ATRAP, novel AT1 receptor associated protein, enhances internalization of AT1 receptor and inhibits vascular smooth muscle cell growth. Biochem. Biophys. Res. Commun. 279 (2000) 938-941
8. Hunyady L., Catt K.J., Clark A.J., and Gaborik Z. Mechanisms and functions of AT(1) angiotensin receptor internalization. Regul. Pept. 91 (2000) 29-44
9. Olivares-Reyes J.A., Smith R.D., Hunyady L., Shah B.H., and Catt K.J. Agonist-induced signaling, desensitization, and internalization of a phosphorylation-deficient AT1A angiotensin receptor. J. Biol. Chem. 276 (2001) 37761-37768
10. Suzuki E., Nishimatsu H., Satonaka H., Walsh K., Goto A., Omata M., et al. Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes. Circ. Res. 90 (2002) 1004-1011
11. Nilsson J., Nilsson L.M., Chen Y.W., Molkentin J.D., Erlinge D., and Gomez M.F. High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler. Thromb Vasc. Biol. 26 (2006) 794-800
12. Huang C., Mattjus P., Ma W.Y., Rincon M., Chen N.Y., Brown R.E., et al. Involvement of nuclear factor of activated T cells activation in UV response. Evidence from cell culture and transgenic mice. J. Biol. Chem. 275 (2000) 9143-9149
13. Horsley V., and Pavlath G.K. NFAT: ubiquitous regulator of cell differentiation and adaptation. J. Cell Biol. 156 (2002) 771-774
14. Dostal D.E. The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function. Regul. Pept. 91 (2000) 1-11
15. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93 (1998) 215-228
16. Guo S., Lopez-Ilasaca M., and Dzau V.J. Identification of calcium-modulating cyclophilin ligand (CAML) as transducer of angiotensin II-mediated nuclear factor of activated T cells (NFAT) activation. J. Biol. Chem. 280 (2005) 12536-12541
17. Kunieda T., Minamino T., Nishi J., Tateno K., Oyama T., Katsuno T., et al. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 114 (2006) 953-960
18. Min L.J., Mogi M., Iwanami J., Li J.M., Sakata A., Fujita T., et al. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence. Cardiovasc. Res. 76 (2007) 506-516
19. Basso N., Paglia N., Stella I., de Cavanagh E.M., Ferder L., del Rosario Lores Arnaiz M., et al. Protective effect of the inhibition of the renin-angiotensin system on aging. Regul. Pept. 128 (2005) 247-252
20. Imanishi T., Hano T., and Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J. Hypertens 23 (2005) 97-104
21. Chen Y., Kelm Jr. R.J., Budd R.C., Sobel B.E., and Schneider D.J. Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1. J. Cell Biochem. 92 (2004) 178-188
22. Min L.J., Mogi M., Iwanami J., Li J.M., Sakata A., Fujita T., et al. Angiotensin II type 2 receptor deletion enhances vascular senescence by methyl methanesulfonate sensitive 2 inhibition. Hypertension 51 (2008) 1339-1344
23. Tsurumi Y., Tamura K., Tanaka Y., Koide Y., Sakai M., Yabana M., et al. Interacting molecule of AT1 receptor, ATRAP, is colocalized with AT1 receptor in the mouse renal tubules. Kidney Int. 69 (2006) 488-494
24. Min L.J., Mogi M., Li J.M., Iwanami J., Iwai M., and Horiuchi M. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. Circ. Res. 97 (2005) 434-442
25. Luo Q., Kang Q., Si W., Jiang W., Park J.K., Peng Y., et al. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 279 (2004) 55958-55968
26. Oshita A., Iwai M., Chen R., Ide A., Okumura M., Fukunaga S., et al. Attenuation of inflammatory vascular remodeling by angiotensin II type 1 receptor-associated protein. Hypertension 48 (2006) 671-676
27. Chainiaux F., Magalhaes J.P., Eliaers F., Remacle J., and Toussaint O. UVB-induced premature senescence of human diploid skin fibroblasts. Int. J. Biochem. Cell. Biol. 34 (2002) 1331-1339
28. Tanaka Y., Tamura K., Koide Y., Sakai M., Tsurumi Y., Noda Y., et al. The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy. FEBS Lett. 579 (2005) 1579-1586
29. Miura S., Saku K., and Karnik S.S. Molecular analysis of the structure and function of the angiotensin II type 1 receptor. Hypertens Res. 26 (2003) 937-943
30. Lopez-Ilasaca M., Liu X., Tamura K., and Dzau V.J. The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol. Biol. Cell 14 (2003) 5038-5050
31. Itahana K., Dimri G.P., Hara E., Itahana Y., Zou Y., Desprez P.Y., et al. A role for p53 in maintaining and establishing the quiescence growth arrest in human cells. J. Biol. Chem. 277 (2002) 18206-18214
32. Ferbeyre G., de Stanchina E., Lin A.W., Querido E., McCurrach M.E., Hannon G.J., et al. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell Biol. 22 (2002) 3497-3508
33. Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 2004;94:110-8.
34. Santini M.P., Talora C., Seki T., Bolgan L., and Dotto G.P. Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9575-9580
35. Rivera A., and Maxwell S.A. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J. Biol. Chem. 280 (2005) 29346-29354
36. Zhang L.H., Youn H.D., and Liu J.O. Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53. J. Biol. Chem. 276 (2001) 43534-43540
37. Conchon S., Barrault M.B., Miserey S., Corvol P., and Clauser E. The C-terminal third intracellular loop of the rat AT1A angiotensin receptor plays a key role in G protein coupling specificity and transduction of the mitogenic signal. J. Biol. Chem. 272 (1997) 25566-25572